Document:

Exhibit 10.5

           

        

           

        Zymergen, Inc

      

         

      2014 Stock Plan

      

         

      Notice of Stock Option Grant (Installment Exercise with Acceleration)

      

         

    

    
      The Optionee has been granted the following option to purchase shares of the Common Stock of Zymergen, Inc.:

      

         

      Name of Optionee: ###PARTICIPANT_NAME###

      

         

      Total Number of Shares: ###TOTAL_AWARDS###

      

         

      Type of Option: ###DICTIONARY_AWARD_NAME###

      

         

      Exercise Price per Share: ###GRANT_PRICE###

      

         

      Date of Grant: ###GRANT_DATE###

      

         

      Date Exercisable: This option may be exercised with respect to the first 25% of the Shares subject to this option when the Optionee completes 12 months of continuous Service beginning with the
        Vesting Commencement Date set forth below. This option may be exercised with respect to an additional 1/48 th of the Shares subject to this option when the Optionee
        completes each month of continuous Service thereafter. This option may become exercisable on an accelerated basis under Section 2(a) of the Stock Option Agreement.

      

         

      Vesting Commencement Date: ###ALTERNATIVE_VEST_BASE_DATE###

      

         

      Expiration Date: ###EXPIRY_DATE###. This option expires earlier if the Optionee’s Service terminates earlier, as provided in Section 6 of the Stock Option Agreement, or if the Company engages in
        certain corporate transactions, as provided in Section 8(b) of the Plan.

      

         

      By signing below, the Optionee and the Company agree that this option is granted under, and governed by the terms and conditions of, the 2014 Stock Plan and the Stock Option Agreement. Both of
        these documents are attached to, and made a part of, this Notice of Stock Option Grant. Section 13 of the Stock Option Agreement includes important acknowledgements of the Optionee.

      

         

      Optionee:                                                                                            Zymergen, Inc.

      

         

      ###PARTICIPANT_NAME###                                                              ###SIGNATURE###

      

         

      THE OPTION GRANTED PURSUANT TO THIS AGREEMENT AND THE SHARES ISSUABLE UPON THE EXERCISE THEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY
        NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

      
        
          

      

       

    
      Zymergen, Inc

      

         

      2014 Stock Plan

      

         

      Stock Option Agreement (Installment Exercise)

      

         

    

    
      SECTION 1. Grant Of Option.

      

         

    

    
      (a) Option. On the terms and conditions set forth in the Notice of Stock Option Grant and this Agreement, the Company grants to the Optionee on the Date
        of Grant the option to purchase at the Exercise Price the number of Shares set forth in the Notice of Stock Option Grant. The Exercise Price is agreed to be at least 100% of the Fair Market Value per Share on the Date of Grant (110% of Fair Market
        Value if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies). This option is intended to be an ISO or an NSO, as provided in the Notice of Stock Option Grant.

    

    
      

         

      (b) $100,000 Limitation. Even if this option is designated as an ISO in the Notice of Stock Option Grant, it shall be deemed to be an NSO to the extent
        (and only to the extent) required by the $100,000 annual limitation under Section 422(d) of the Code.

      

         

      (c) Stock Plan and Defined Terms. This option is granted pursuant to the Plan, a copy of which the Optionee acknowledges having received. The provisions
        of the Plan are incorporated into this Agreement by this reference. Except as otherwise defined in this Agreement (including without limitation Section 14 hereof), capitalized terms shall have the meaning ascribed to such terms in the Plan.

      

         

      SECTION 2. Right To Exercise.

      

         

      (a) Exercisability. Subject to Subsection (b) below and the other conditions set forth in this Agreement, all or part of this option may be exercised
        prior to its expiration at the time or times set forth in the Notice of Stock Option Grant. In addition, the following rules shall apply if the Company is subject to a Change in Control before the Optionee’s Service terminates:

      

         

      (i) At all times after the Change in Control, the exercisable portion of this option shall be determined by adding 12 months to the Optionee’s actual Service.

      

         

      (ii) If the Optionee is subject to an Involuntary Termination within 12 months after the Change in Control, then 100% of the Shares subject to this option shall become vested and exercisable.

      

         

      (b) Stockholder Approval. Any other provision of this Agreement notwithstanding, no portion of this option shall be exercisable at any time prior to the
        approval of the Plan by the Company’s stockholders.

      

         

      SECTION 3. No Transfer Or Assignment Of Option.

      

         

      Except as otherwise provided in this Agreement, this option and the rights and privileges conferred hereby shall not be sold, pledged or otherwise transferred (whether by operation of law or
        otherwise) and shall not be subject to sale under execution, attachment, levy or similar process.

      
        
          

      

      SECTION 4. Exercise Procedures.

      

         

      (a) Notice of Exercise. The Optionee or the Optionee’s representative may exercise this option by: (i) signing and delivering written notice to the
        Company pursuant to Section 12(c) specifying the election to exercise this option, the number of Shares for which it is being exercised and the form of payment and (ii) delivering payment, in a form permissible under Section 5, for the full amount
        of the Purchase Price (together with any applicable withholding taxes under Subsection (b)). In the event that this option is being exercised by the representative of the Optionee, the notice shall be accompanied by proof (satisfactory to the
        Company) of the representative’s right to exercise this option.

      

         

      (b) Withholding Taxes. In the event that the Company determines that it is required to withhold any tax (including without limitation any income tax,
        social insurance contributions, payroll tax, payment on account or other tax-related items arising in connection with the Optionee’s participation in the Plan and legally applicable to the Optionee (the “Tax-Related
          Items”)) as a result of the grant, vesting or exercise of this option, or as a result of the transfer of shares acquired upon exercise of this option, the Optionee, as a condition of this option, shall make arrangements satisfactory to the
        Company to enable it to satisfy all Tax-Related Items. The Optionee acknowledges that the responsibility for all Tax-Related Items is the Optionee’s and may exceed the amount actually withheld by the Company (or its affiliate or agent).

      

         

      (c) Issuance of Shares. After satisfying all requirements for exercise of this option, the Company shall cause to be issued one or more certificates
        evidencing the Shares for which this option has been exercised. Such Shares shall be registered (i) in the name of the person exercising this option, (ii) in the names of such person and his or her spouse as community property or as joint tenants
        with the right of survivorship or (iii) with the Company’s consent, in the name of a revocable trust. Until the issuance of the Shares has been entered into the books and records of the Company or a duly authorized transfer agent of the Company, no
        right to vote, receive dividends or any other right as a stockholder will exist with respect to such Shares. The Company shall cause such certificates to be delivered to or upon the order of the person exercising this option.

      

         

      SECTION 5. Payment For Stock.

      

         

      (a) Cash. All or part of the Purchase Price may be paid in cash or cash equivalents.

      

         

      (b) Surrender of Stock. At the discretion of the Board of Directors, all or any part of the Purchase Price may be paid by surrendering, or attesting to
        the ownership of, Shares that are already owned by the Optionee. Such Shares shall be surrendered to the Company in good form for transfer and shall be valued at their Fair Market Value as of the date when this option is exercised.

      

         

      (c) Exercise/Sale. All or part of the Purchase Price and any withholding taxes may be paid by the delivery (on a form prescribed by the Company) of an
        irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sales proceeds to the Company. However, payment pursuant to this Subsection (c) shall be permitted only if (i) Stock then is
        publicly traded and (ii) such payment does not violate applicable law.

      
        
          

      

      SECTION 6. Term And Expiration.

      

         

      (a) Basic Term. This option shall in any event expire on the expiration date set forth in the Notice of Stock Option Grant, which date is 10 years after
        the Date of Grant (five years after the Date of Grant if this option is designated as an ISO in the Notice of Stock Option Grant and Section 3(b) of the Plan applies).

      

         

      (b) Termination of Service (Except by Death). If the Optionee’s Service terminates for any reason other than death, then this option shall expire on the
        earliest of the following occasions:

      

         

      (i) The expiration date determined pursuant to Subsection (a) above;

      

         

      (ii) The date three months after the termination of the Optionee’s Service for any reason other than Disability; or

      

         

      (iii) The date six months after the termination of the Optionee’s Service by reason of Disability.

      

         

      The Optionee may exercise all or part of this option at any time before its expiration under the preceding sentence, but only to the extent that this option had become exercisable before the
        Optionee’s Service terminated. When the Optionee’s Service terminates, this option shall expire immediately with respect to the number of Shares for which this option is not yet exercisable. In the event that the Optionee dies after termination of
        Service but before the expiration of this option, all or part of this option may be exercised (prior to expiration) by the executors or administrators of the Optionee’s estate or by any person who has acquired this option directly from the Optionee
        by beneficiary designation, bequest or inheritance, but only to the extent that this option had become exercisable before the Optionee’s Service terminated. Once this option (or portion thereof) has terminated, the Optionee shall have no further
        rights with respect to the option (or portion thereof) or to the underlying Shares.

      

         

      (c) Death of the Optionee. If the Optionee dies while in Service, then this option shall expire on the earlier of the following dates:

      

         

      (i) The expiration date determined pursuant to Subsection (a) above; or

      

         

      (ii) The date 12 months after the Optionee’s death.

      

         

      All or part of this option may be exercised at any time before its expiration under the preceding sentence by the executors or administrators of the Optionee’s estate or by any person who has
        acquired this option directly from the Optionee by beneficiary designation, bequest or inheritance, but only to the extent that this option had become exercisable before the Optionee’s death. When the Optionee dies, this option shall expire
        immediately with respect to the number of Shares for which this option is not yet exercisable. Once this option (or portion thereof) has terminated, the Optionee shall have no further rights with respect to the option (or portion thereof) or to the
        underlying Shares.

      

         

      (d) Extension of Post-Termination Exercise Periods. Following the date on which the Company’s Stock is first listed for trading on an established
        securities market, if during any part of the exercise period described in Subsections (b)(ii) or (iii) or Subsection (c)(ii) above the exercise of this option would be prohibited solely because the issuance of Shares upon such exercise would
        violate the registration requirements under the Securities Act or a similar provision of other applicable law, then instead of terminating at the end of such prescribed period, the then-vested portion of this option will instead remain outstanding
        and not expire until the earlier of (i) the expiration date determined pursuant to Section 6(a) above or (ii) the date on which the then-vested portion of this option has been exercisable without violation of applicable law for the aggregate period
        (which need not be consecutive) after termination of the Optionee’s Service specified in the applicable Subsection above.

      
        
          

      

      (e) Part-Time Employment and Leaves of Absence. If the Optionee commences working on a part-time basis, then the Company may adjust the vesting schedule
        set forth in the Notice of Stock Option Grant. If the Optionee goes on a leave of absence, then the Company may adjust the vesting schedule set forth in the Notice of Stock Option Grant in accordance with the Company’s leave of absence policy or
        the terms of such leave. Except as provided in the preceding sentence, Service shall be deemed to continue for any purpose under this Agreement while the Optionee is on a bona fide leave of absence, if (i)
        such leave was approved by the Company in writing and (ii) continued crediting of Service for such purpose is expressly required by the terms of such leave or by applicable law (as determined by the Company). Service shall be deemed to terminate
        when such leave ends, unless the Optionee immediately returns to active work.

      

         

      (f) Notice Concerning ISO Treatment. Even if this option is designated as an ISO in the Notice of Stock Option Grant, it ceases to qualify for favorable
        tax treatment as an ISO to the extent that it is exercised:

      

         

      (i) More than three months after the date when the Optionee ceases to be an Employee for any reason other than death or permanent and total disability (as defined in Section 22(e)(3) of the
        Code);

      

         

      (ii) More than 12 months after the date when the Optionee ceases to be an Employee by reason of permanent and total disability (as defined in Section 22(e)(3) of the Code); or

      

         

      (iii) More than three months after the date when the Optionee has been on a leave of absence for three months, unless the Optionee’s reemployment rights following such leave were guaranteed by
        statute or by contract.

      

         

      SECTION 7. Right Of First Refusal.

      

         

      (a) Right of First Refusal. In the event that the Optionee proposes to sell, pledge or otherwise transfer to a third party any Shares acquired under this
        Agreement, or any interest in such Shares, the Company shall have the Right of First Refusal with respect to all (and not less than all) of such Shares. If the Optionee desires to transfer Shares acquired under this Agreement, the Optionee shall
        give a written Transfer Notice to the Company describing fully the proposed transfer, including the number of Shares proposed to be transferred, the proposed transfer price, the name and address of the proposed Transferee and proof satisfactory to
        the Company that the proposed sale or transfer will not violate any applicable federal, State or foreign securities laws. The Transfer Notice shall be signed both by the Optionee and by the proposed Transferee and must constitute a binding
        commitment of both parties to the transfer of the Shares. The Company shall have the right to purchase all, and not less than all, of the Shares on the terms of the proposal described in the Transfer Notice (subject, however, to any change in such
        terms permitted under Subsection (b) below) by delivery of a notice of exercise of the Right of First Refusal within 30 days after the date when the Transfer Notice was received by the Company.

      
        
          

      

      (b) Transfer of Shares. If the Company fails to exercise its Right of First Refusal within 30 days after the date when it received the Transfer Notice,
        the Optionee may, not later than 90 days following receipt of the Transfer Notice by the Company, conclude a transfer of the Shares subject to the Transfer Notice on the terms and conditions described in the Transfer Notice, provided that any such
        sale is made in compliance with applicable federal, State and foreign securities laws and not in violation of any other contractual restrictions to which the Optionee is bound. Any proposed transfer on terms and conditions different from those
        described in the Transfer Notice, as well as any subsequent proposed transfer by the Optionee, shall again be subject to the Right of First Refusal and shall require compliance with the procedure described in Subsection (a) above. If the Company
        exercises its Right of First Refusal, the parties shall consummate the sale of the Shares on the terms set forth in the Transfer Notice within 60 days after the date when the Company received the Transfer Notice (or within such longer period as may
        have been specified in the Transfer Notice); provided, however, that in the event the Transfer Notice provided that payment for the Shares was to be made in a form other than cash or cash equivalents paid at the time of transfer, the Company shall
        have the option of paying for the Shares with cash or cash equivalents equal to the present value of the consideration described in the Transfer Notice.

      

         

      (c) Additional or Exchanged Securities and Property. In the event of a merger or consolidation of the Company, a sale of all or substantially all of the
        Company’s stock or assets, any other corporate reorganization, a stock split, the declaration of a stock dividend, the declaration of an extraordinary dividend payable in a form other than stock, a spin‐off, an adjustment in conversion ratio, a
        recapitalization or a similar transaction affecting the Company’s outstanding securities, any securities or other property (including cash or cash equivalents) that are by reason of such transaction exchanged for, or distributed with respect to,
        any Shares subject to this Section 7 shall immediately be subject to the Right of First Refusal. Appropriate adjustments to reflect the exchange or distribution of such securities or property shall be made to the number and/or class of the Shares
        subject to this Section 7.

      

         

      (d) Termination of Right of First Refusal. Any other provision of this Section 7 notwithstanding, in the event that the Stock is readily tradable on an
        established securities market when the Optionee desires to transfer Shares, the Company shall have no Right of First Refusal, and the Optionee shall have no obligation to comply with the procedures prescribed by Subsections (a) and (b) above.

      

         

      (e) Permitted Transfers. This Section 7 shall not apply to (i) a transfer by beneficiary designation, will or intestate succession or (ii) a transfer to
        one or more members of the Optionee’s Immediate Family or to a trust established by the Optionee for the benefit of the Optionee and/or one or more members of the Optionee’s Immediate Family, provided in either case that the Transferee agrees in
        writing on a form prescribed by the Company to be bound by all provisions of this Agreement. If the Optionee transfers any Shares acquired under this Agreement, either under this Subsection (e) or after the Company has failed to exercise the Right
        of First Refusal, then this Agreement shall apply to the Transferee to the same extent as to the Optionee.

      

         

      (f) Termination of Rights as Stockholder. If the Company makes available, at the time and place and in the amount and form provided in this Agreement, the
        consideration for the Shares to be purchased in accordance with this Section 7, then after such time the person from whom such Shares are to be purchased shall no longer have any rights as a holder of such Shares (other than the right to receive
        payment of such consideration in accordance with this Agreement). Such Shares shall be deemed to have been purchased in accordance with the applicable provisions hereof, whether or not the certificate(s) therefor have been delivered as required by
        this Agreement.

      
        
          

      

      (g) Assignment of Right of First Refusal. The Board of Directors may freely assign the Company’s Right of First Refusal, in whole or in part. Any person
        who accepts an assignment of the Right of First Refusal from the Company shall assume all of the Company’s rights and obligations under this Section 7.

      

         

      SECTION 8. Legality Of Initial Issuance.

      

         

      No Shares shall be issued upon the exercise of this option unless and until the Company has determined that:

      

         

      (a) It and the Optionee have taken any actions required to register the Shares under the Securities Act or to perfect an exemption from the registration requirements thereof;

      

         

      (b) Any applicable listing requirement of any stock exchange or other securities market on which Stock is listed has been satisfied; and

      

         

      (c) Any other applicable provision of federal, State or foreign law has been satisfied.

      

         

      SECTION 9. No Registration Rights.

      

         

      The Company may, but shall not be obligated to, register or qualify the sale of Shares under the Securities Act or any other applicable law. The Company shall not be obligated to take any
        affirmative action in order to cause the sale of Shares under this Agreement to comply with any law.

      

         

      SECTION 10. Restrictions On Transfer of shares.

      

         

      (a) Securities Law Restrictions. Regardless of whether the offer and sale of Shares under the Plan have been registered under the Securities Act or have
        been registered or qualified under the securities laws of any State or other relevant jurisdiction, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such Shares (including the placement of appropriate
        legends on the stock certificates (or electronic equivalent) or the imposition of stop-transfer instructions) and may refuse (or may be required to refuse) to transfer Shares acquired hereunder (or Shares proposed to be transferred in a subsequent
        transfer) if, in the judgment of the Company, such restrictions, legends or refusal are necessary or appropriate to achieve compliance with the Securities Act or other relevant securities or other laws, including without limitation under Regulation
        S of the Securities Act or pursuant to another available exemption from registration.

      

         

      (b) Market Stand-Off. In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration
        statement filed under the Securities Act, including the Company’s initial public offering, the Optionee or a Transferee shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or
        other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Agreement
        without the prior written consent of the Company or its managing underwriter. Such restriction (the “Market Stand-Off”) shall be in effect for such period of time following the date of the final prospectus
        for the offering as may be requested by the Company or such underwriter. In no event, however, shall such period exceed 180 days plus such additional period as may reasonably be requested by the Company or such underwriter to accommodate regulatory
        restrictions on (i) the publication or other distribution of research reports or (ii) analyst recommendations and opinions, including (without limitation) the restrictions set forth in Rule 2711(f)(4) of the National Association of Securities
        Dealers and Rule 472(f)(4) of the New York Stock Exchange, as amended, or any similar successor rules. The Market Stand-Off shall in any event terminate two years after the date of the Company’s initial public offering. In the event of the
        declaration of a stock dividend, a spin‐off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding securities without receipt of consideration, any new, substituted or
        additional securities which are by reason of such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall immediately be subject to the Market Stand-Off. In
        order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under this Agreement until the end of the applicable stand-off period. The Company’s underwriters shall be beneficiaries of
        the agreement set forth in this Subsection (b). This Subsection (b) shall not apply to Shares registered in the public offering under the Securities Act.

      
        
          

      

      (c) Investment Intent at Grant. The Optionee represents and agrees that the Shares to be acquired upon exercising this option will be acquired for
        investment, and not with a view to the sale or distribution thereof.

      

         

      (d) Investment Intent at Exercise. In the event that the sale of Shares under the Plan is not registered under the Securities Act but an exemption is
        available that requires an investment representation or other representation, the Optionee shall represent and agree at the time of exercise that the Shares being acquired upon exercising this option are being acquired for investment, and not with
        a view to the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company and its counsel, including (if applicable because the Company is relying on Regulation S under the
        Securities Act) that as of the date of exercise the Optionee is (i) not a U.S. Person; (ii) not acquiring the Shares on behalf, or for the account or benefit, of a U.S. Person; and (iii) is not exercising the option in the United States.

      

         

      (e) Legends. All certificates evidencing Shares purchased under this Agreement shall bear the following legend:

      

         

      “THE SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND
        THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). SUCH AGREEMENT GRANTS TO THE COMPANY CERTAIN RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SHARES. IN ADDITION, THE SHARES ARE SUBJECT TO RESTRICTIONS
        ON TRANSFER FOR A LIMITED PERIOD FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY’S SECURITIES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER.
        THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.”

      
        
          

      

      All certificates evidencing Shares purchased under this Agreement in an unregistered transaction shall bear the following legend (and such other restrictive legends as are required or deemed
        advisable under the provisions of any applicable law):

      

         

      “THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY SECURITIES LAWS OF ANY U.S. STATE, AND MAY NOT BE SOLD, REOFFERED, PLEDGED,
        ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. IN THE ABSENCE OF
        REGISTRATION OR THE AVAILABILITY (CONFIRMED BY OPINION OF COUNSEL) OF AN ALTERNATIVE EXEMPTION FROM REGISTRATION UNDER THE ACT (INCLUDING WITHOUT LIMITATION IN ACCORDANCE WITH REGULATION S UNDER THE ACT), THESE SHARES MAY NOT BE SOLD, REOFFERED,
        PLEDGED, ASSIGNED, ENCUMBERED OR OTHERWISE TRANSFERRED OR DISPOSED OF. HEDGING TRANSACTIONS INVOLVING THESE SHARES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.”

      

         

      (f) Removal of Legends. If, in the opinion of the Company and its counsel, any legend placed on a stock certificate representing Shares sold under this
        Agreement is no longer required, the holder of such certificate shall be entitled to exchange such certificate for a certificate representing the same number of Shares but without such legend.

      

         

      (g) Administration. Any determination by the Company and its counsel in connection with any of the matters set forth in this Section 10 shall be
        conclusive and binding on the Optionee and all other persons.

      

         

      SECTION 11. Adjustment Of Shares.

      

         

      In the event of any transaction described in Section 8(a) of the Plan, the terms of this option (including, without limitation, the number and kind of Shares subject to this option and the
        Exercise Price) shall be adjusted as set forth in Section 8(a) of the Plan. In the event that the Company is a party to a merger or consolidation or in the event of a sale of all or substantially all of the Company’s stock or assets, this option
        shall be subject to the treatment provided by the Board of Directors in its sole discretion, as provided in Section 8(b) of the Plan.

      

         

      SECTION 12. Miscellaneous Provisions.

      

         

      (a) Rights as a Stockholder. Neither the Optionee nor the Optionee’s representative shall have any rights as a stockholder with respect to any Shares
        subject to this option until the Optionee or the Optionee’s representative becomes entitled to receive such Shares by filing a notice of exercise and paying the Purchase Price pursuant to Sections 4 and 5.

      
        
          

      

      (b) No Retention Rights. Nothing in this option or in the Plan shall confer upon the Optionee any right to continue in Service for any period of specific
        duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining the Optionee) or of the Optionee, which rights are hereby expressly reserved by each, to terminate his or her
        Service at any time and for any reason, with or without cause.

      

         

      (c) Notice. Any notice required by the terms of this Agreement shall be given in writing. It shall be deemed effective upon (i) personal delivery, (ii)
        deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, (iii) deposit with Federal Express Corporation, with shipping charges prepaid or (iv) deposit with any internationally recognized express
        mail courier service. Notice shall be addressed to the Company at its principal executive office and to the Optionee at the address that he or she most recently provided to the Company in accordance with this Subsection (c).

      

         

      (d) Modifications and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is
        agreed to in writing and signed by the Optionee and by an authorized officer of the Company (other than the Optionee). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other
        party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

      

         

      (e) Entire Agreement. The Notice of Stock Option Grant, this Agreement and the Plan constitute the entire contract between the parties hereto with regard
        to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or implied) that relate to the subject matter hereof.

      

         

      (f) Choice of Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, as such laws are applied to
        contracts entered into and performed in such State.

      

         

      SECTION 13. Acknowledgements of the Optionee.

      

         

      In addition to the other terms, conditions and restrictions imposed on this option and the Shares issuable under this option pursuant to this Agreement and the Plan, the Optionee expressly
        acknowledges being subject to Sections 7 (Right of First Refusal), 8 (Legality of Initial Issuance) and 10 (Restrictions on Transfer of Shares, including without limitation the Market Stand-Off), as well as the following provisions:

      

         

      (a) Tax Consequences (No Liability for Discounted Options). The Optionee agrees that the Company does not have a duty to design or administer the Plan or
        its other compensation programs in a manner that minimizes the Optionee’s tax liabilities. The Optionee shall not make any claim against the Company or its Board of Directors, officers or employees related to tax liabilities arising from this
        option or the Optionee’s other compensation. In particular, any Optionee subject to U.S. taxation acknowledges that this option is exempt from Section 409A of the Code only if the Exercise Price is at least equal to the Fair Market Value per Share
        on the Date of Grant. Since Shares are not traded on an established securities market, the determination of their Fair Market Value is made by the Board of Directors or by an independent valuation firm retained by the Company. The Optionee
        acknowledges that there is no guarantee in either case that the Internal Revenue Service will agree with the valuation, and the Optionee shall not make any claim against the Company or its Board of Directors, officers or employees in the event that
        the Internal Revenue Service asserts that the valuation was too low.

      
        
          

      

      (b) Electronic Delivery of Documents. The Optionee agrees to accept by email all documents relating to the Company, the Plan or this option and all other
        documents that the Company is required to deliver to its security holders (including, without limitation, disclosures that may be required by the Securities and Exchange Commission). The Optionee also agrees that the Company may deliver these
        documents by posting them on a website maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a website, it shall notify the Optionee by email of their availability. The Optionee
        acknowledges that he or she may incur costs in connection with electronic delivery, including the cost of accessing the internet and printing fees, and that an interruption of internet access may interfere with his or her ability to access the
        documents. This consent shall remain in effect until this option expires or until the Optionee gives the Company written notice that it should deliver paper documents.

      

         

      (c) No Notice of Expiration Date. The Optionee agrees that the Company and its officers, employees, attorneys and agents do not have any obligation to
        notify him or her prior to the expiration of this option pursuant to Section 6, regardless of whether this option will expire at the end of its full term or on an earlier date related to the termination of the Optionee’s Service. The Optionee
        further agrees that he or she has the sole responsibility for monitoring the expiration of this option and for exercising this option, if at all, before it expires. This Subsection (c) shall supersede any contrary representation that may have been
        made, orally or in writing, by the Company or by an officer, employee, attorney or agent of the Company.

      

         

      (d) Waiver of Statutory Information Rights. The Optionee acknowledges and agrees that, upon exercise of this option and until the first sale of the
        Company’s Stock to the general public pursuant to a registration statement filed under the Securities Act, he or she will be deemed to have waived any rights the Optionee might otherwise have had under Section 220 of the Delaware General
        Corporation Law (or under similar rights under other applicable law) to inspect for any proper purpose and to make copies and extracts from the Company’s stock ledger, a list of its stockholders and its other books and records or the books and
        records of any subsidiary. This waiver applies only in the Optionee’s capacity as a stockholder and does not affect any other inspection rights the Optionee may have under other law or pursuant to a written agreement with the Company.

      

         

      (e) Plan Discretionary. The Optionee understands and acknowledges that (i) the Plan is entirely discretionary, (ii) the Company and the Optionee’s
        employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of an option does not in any way create any contractual or other right to receive additional grants of options (or benefits in lieu of options) at
        any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when options will be granted, the number of Shares offered, the Exercise Price and the vesting schedule, will be
        at the sole discretion of the Company.

      
        
          

      

      (f) Termination of Service. The Optionee understands and acknowledges that participation in the Plan ceases upon termination of his or her Service for any
        reason, except as may explicitly be provided otherwise in the Plan or this Agreement.

      

         

      (g) Extraordinary Compensation. The value of this option shall be an extraordinary item of compensation outside the scope of the Optionee’s employment
        contract, if any, and shall not be considered a part of his or her normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement
        benefits or similar payments.

      

         

      (h) Authorization to Disclose. The Optionee hereby authorizes and directs the Optionee’s employer to disclose to the Company or any Subsidiary any
        information regarding the Optionee’s employment, the nature and amount of the Optionee’s compensation and the fact and conditions of the Optionee’s participation in the Plan, as the Optionee’s employer deems necessary or appropriate to facilitate
        the administration of the Plan.

      

         

      (i) Personal Data Authorization. The Optionee consents to the collection, use and transfer of personal data as described in this Subsection (i). The
        Optionee understands and acknowledges that the Company, the Optionee’s employer and the Company’s other Subsidiaries hold certain personal information regarding the Optionee for the purpose of managing and administering the Plan, including (without
        limitation) the Optionee’s name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or directorships held in the Company and details of all options or any other entitlements to Shares
        awarded, canceled, exercised, vested, unvested or outstanding in the Optionee’s favor (the “Data”). The Optionee further understands and acknowledges that the Company and/or its Subsidiaries will transfer
        Data among themselves as necessary for the purpose of implementation, administration and management of the Optionee’s participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting
        the Company in the implementation, administration and management of the Plan. The Optionee understands and acknowledges that the recipients of Data may be located in the United States or elsewhere. The Optionee authorizes such recipients to
        receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose of administering the Optionee’s participation in the Plan, including a transfer to any broker or other third party with whom the Optionee elects to
        deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on the Optionee’s behalf. The Optionee may, at any time, view the Data, require any necessary
        modifications of Data or withdraw the consents set forth in this Subsection (i) by contacting the Company in writing.

      

         

      SECTION 14. Definitions.

      

         

      (a) “Agreement” shall mean this Stock Option Agreement.

      

         

      (b) “Board of Directors” shall mean the Board of Directors of the Company, as constituted from time to time or, if a Committee has been appointed, such
        Committee.

      

         

      (c) “Cause” shall mean:

      
        
          

      

      (i) An unauthorized use or disclosure by the Optionee of the Company’s confidential information or trade secrets, which use or disclosure causes material harm to the Company;

      

         

      (ii) A material breach by the Optionee of any agreement between the Optionee and the Company;

      

         

      (iii) A material failure by the Optionee to comply with the Company’s written policies or rules;

      

         

      (iv) The Optionee’s conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any State thereof;

      

         

      (v) The Optionee’s gross negligence or willful misconduct;

      

         

      (vi) A continuing failure by the Optionee to perform assigned duties after receiving written notification of such failure from the Board of Directors; or

      

         

      (vii) A failure by the Optionee to cooperate in good faith with a governmental or internal investigation of the Company or its directors, officers or employees, if the Company has requested the
        Optionee’s cooperation.

      

         

      (d) “Change in Control” shall mean (i) the consummation of a merger or consolidation of the Company with or into another entity or (ii) the dissolution,
        liquidation or winding up of the Company. The foregoing notwithstanding, a merger or consolidation of the Company shall not constitute a “Change in Control” if immediately after such merger or consolidation a majority of the voting power of the
        capital stock of the continuing or surviving entity, or any direct or indirect parent corporation of such continuing or surviving entity, will be owned by the persons who were the Company’s shareholders immediately prior to such merger or
        consolidation in substantially the same proportions as their ownership of the voting power of the Company’s capital stock immediately prior to such merger or consolidation.

      

         

      (e) “Company” shall mean Zymergen, Inc., a Delaware corporation.

      

         

      (f) “Good Reason” shall mean that the Optionee resigns within 12 months after one of the following conditions has come into existence without his or her
        consent:

      

         

      (i) A reduction in the Optionee’s base salary by more than 10%;

      

         

      (ii) A material diminution of the Optionee’s authority, duties or responsibilities; or

      

         

      (iii) A relocation of the Optionee’s principal workplace by more than 30 miles.

      

         

      A condition shall not be considered “Good Reason” unless the Optionee gives the Company written notice of such condition within 90 days after such condition comes into existence and the Company
        fails to remedy such condition within 30 days after receiving the Optionee’s written notice.

      

         

      (g) “Immediate Family” shall mean any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law,
        son-in-law, daughter-in-law, brother-in-law or sister-in-law and shall include adoptive relationships.

      
        
          

      

      (h) “Involuntary Termination” shall mean the termination of the Optionee’s Service by reason of:

      

         

      (i) The involuntary discharge of the Optionee by the Company (or the Parent or Subsidiary employing him or her) for reasons other than Cause; or

      

         

      (ii) The voluntary resignation of the Optionee for Good Reason.

      

         

      (i) “Optionee” shall mean the person named in the Notice of Stock Option Grant.

      

         

      (j) “Plan” shall mean the Zymergen, Inc. 2014 Stock Plan, as in effect on the Date of Grant.

      

         

      (k) “Purchase Price” shall mean the Exercise Price multiplied by the number of Shares with respect to which this option is being exercised.

      

         

      (l) “Right of First Refusal” shall mean the Company’s right of first refusal described in Section 7.

      

         

      (m) “Service” means service as an Employee, Outside Director or Consultant.

      

         

      (n) “Transferee” shall mean any person to whom the Optionee has directly or indirectly transferred any Share
        acquired under this Agreement.

      

         

      (o) “Transfer Notice” shall mean the notice of a proposed transfer of Shares described in Section 7.

      

         

      (p) “U.S. Person” shall mean a person described in Rule 902(k) of Regulation S of the Securities Act (or any successor rule or provision), which generally
        defines a U.S. person as any natural person resident in the United States, any estate of which any executor or administrator is a U.S. Person, or any trust of which of any trustee is a U.S. Person.Exhibit 10.11

    

    
      

      

      ZYMERGEN INC.

      

      

      EMPLOYMENT AGREEMENT

      

      

    

    
      This Employment Agreement (the “Agreement”), is made and entered into by and between Zymergen Inc., a Delaware
        corporation (the “Company”) and [________________] (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective
        (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of [________________] (“Offer Letter”).

      

      

      WHEREAS, the Company desires to assure itself of the continued services of Executive by engaging
        Executive to perform services as an employee of the Company under the terms hereof;

      

      

      WHEREAS, Executive desires to provide continued services to the Company on the terms herein provided; and

      

      

      WHEREAS, the Parties desire to execute this Agreement to supersede the Offer Letter in its entirety and reflect certain changes to
        Executive’s employment with the Company effective as of the Effective Date.

      

      

      NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants and
        agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:

      

      

    

    
      	

            	1.	
              Employment.

            

    

    
      

      

    

    
      (a)          General. The Company shall employ Executive upon the terms and conditions provided herein effective as of
          the Effective Date.

    

    
      

      

    

    
      (b)          Position and Duties. Effective as of the Effective Date, Executive: (i) shall continue to serve as the
          Company’s [________________]1,with such responsibilities, duties, and authority as Executive has as of the Effective Date or that are usual and customary for such
          position, subject to direction by the [Board of Directors of the Company (the “Board”)] [Chief Executive Officer]; (ii) shall continue to report directly to [the Board] [Chief Executive
          Officer]; and (iii) agrees promptly and faithfully to comply with all present and future policies, requirements, rules and regulations, and reasonable directions and requests, of the Company in connection with the Company’s business. At the
          Company’s request, Executive shall serve the Company and/or its subsidiaries and affiliates in such other capacities in addition to the foregoing as the Company shall designate, provided that such additional capacities are consistent with
          Executive’s position as the Company’s [________________]. In the event that Executive serves in any one or more of such additional capacities, Executive’s compensation shall not automatically be increased on account of such additional service.

    

    
      

      

    

    
      (c)          Principal Office. Executive shall continue to perform services for the Company [at the Company’s offices
          located in Emeryville, California,] or, with the Company’s consent, at any other place in connection with the fulfillment of Executive’s role with the Company; provided, however, that the Company may from time to time require Executive to travel
          temporarily to other locations in connection with the Company’s business.

    

    

    

    

    1 Josh Hoffman – Co-Founder and Chief Executive Officer; Jed Dean – Co-Founder and VP, Operations and Engineering; Mina Kim – Chief Legal
      Officer; Aaron Kimball – Chief Technology Officer; Zachariah Serber – Co-Founder and Chief Science Officer; Enakshi Singh - Chief Financial Officer.

    
      
        

    

    
      

      

    

    
      (d)          Exclusivity. Except with the prior written approval of the [Board] [Board of Directors of the Company (the “Board”)] (which the Board may grant or withhold in its sole and absolute discretion), Executive shall devote Executive’s best efforts and full working time, attention, and energies to the
          business of the Company, except during any paid vacation or other excused absence periods. Notwithstanding the foregoing, Executive may, without violating this Section 1(d), (i) as a passive investment, own publicly traded securities in such form
          or manner as will not require any services by Executive in the operation of the entities in which such securities are owned; (ii) engage in charitable and civic activities; or (iii) engage in other personal passive investment activities, in each
          case, so long as such interests or activities do not materially interfere to the extent such activities do not, individually or in the aggregate, interfere with or otherwise prevent the performance of Executive’s duties and responsibilities
          hereunder. Executive may also serve as a member of the board of directors or board of advisors of another organization provided (i) such organization is not a competitor of the Company; (ii) Executive receives prior written approval from the
          [Board] [Chief Executive Officer]; and (iii) such activities do not individually or in the aggregate interfere with the performance of Executive’s duties under this Agreement, violate the Company’s standards of conduct then in effect, or raise a
          conflict under the Company’s conflict of interest policies. For the avoidance of doubt, the [Board] [Chief Executive Officer] has approved Executive’s continued service with those organizations set forth on Exhibit A, such approval to
          continue until the earlier to occur of (a) the [Board’s] [Chief Executive Officer’s] revocation of such approval in [its] [his or her] sole and absolute discretion upon reasonable notice to Executive, or (b) such time as such service interferes
          with the performance of Executive’s duties under this Agreement, violates the Company’s standards of conflict or raises a conflict under the Company’s conflict of interest policies.

    

    
      

      

    

    
      2.          Term. The period of Executive’s employment under this
          Agreement shall commence on the Effective Date and shall continue until Executive’s employment with the Company is terminated pursuant to Section 5. The phrase “Term” as used in this
          Agreement shall refer to the entire period of employment of Executive by the Company.

    

    
      

      

    

    
      3.          Compensation and Related Matters.

    

    
      

      

    

    
      (a)          Annual Base Salary. During the Term, Executive shall receive a base salary at the rate of $[________]2 per year (as may be increased from time to time, the “Annual Base Salary”), subject to withholdings and
          deductions, which shall be paid to Executive in accordance with the customary payroll practices and procedures of the Company. Such Annual Base Salary shall be reviewed by the Board, not less than annually.

    

    
      

      

    

    
      (b)          Annual Bonus. Executive shall be eligible to receive a discretionary annual bonus based on Executive’s
          achievement of performance objectives established by the Board, such bonus to be targeted at [__]%3 of Executive’s Annual Base Salary (the “Annual Bonus”). Any Annual Bonus approved by the Board shall be paid at the same time annual bonuses are paid to other executives of the Company generally, subject to Executive’s continuous employment through
          the date of approval.

    

    
      

      

    

    
      (c)          Benefits. Executive shall be entitled to participate in such employee and executive benefit plans and programs
          as the Company may from time to time offer to provide to its executives, subject to the terms and conditions of such plans. Notwithstanding the foregoing, nothing herein is intended, or shall be construed, to require the Company to institute or
          continue any particular plan or benefit.

    

    
      

      

    

    
      (d)          Business Expenses. The Company shall reimburse Executive for all reasonable, documented, out-of-pocket travel
          and other business expenses incurred by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s applicable expense reimbursement policies and procedures as are in effect from time to time.

    

    
      

      

    

    
      (e)          Vacation. Executive will be entitled to paid vacation in accordance with the Company’s vacation policy, as in
          effect from time to time.

      

      

      

      2 $500,000 for Josh Hoffman; $400,000 for Mina Kim and Enakshi Singh; $360,000 for Aaron Kimball;
        $350,000 for Zachariah Serber and Jed Dean.

      

      

      3 60% for Josh Hoffman; 50% for other executive officers.

      
        
          

      

      

      

    

    
      4.          Equity Awards. Executive shall be eligible for the grant
          of stock options and other equity awards as may be determined by the Board or its Compensation Committee.

    

    
      

      

    

    
      5.          Termination.

    

    
      

      

    

    
      (a)          At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and shall continue to
          be at-will, as defined under applicable law. This means that it is not for any specified period of time and, subject to any ramifications under Section 6 of this Agreement, can be terminated by Executive or by the Company at any time, with or
          without advance notice, and for any or no particular reason or cause. It also means that Executive’s job duties, title, and responsibility and reporting level, work schedule, compensation, and benefits, as well as the Company’s personnel policies
          and procedures, may be changed with prospective effect, with or without notice, at any time in the sole discretion of the Company (subject to any ramification such changes may have under Section 6 of this Agreement). This “at-will” nature of
          Executive’s employment shall remain unchanged during Executive’s tenure as an employee and may not be changed, except in an express writing signed by Executive and a duly-authorized officer of the Company. If Executive’s employment terminates for
          any lawful reason, Executive shall not be entitled to any payments, benefits, damages, award, or compensation other than as provided in this Agreement.

    

    
      

      

    

    
      (b)          Notice of Termination. During the Term, any termination of Executive’s employment by the Company or by
          Executive (other than by reason of death) shall be communicated by written notice (a “Notice of Termination”) from one Party hereto to the other Party hereto (i) indicating the specific
          termination provision in this Agreement relied upon, if any, (ii) setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated, and (iii)
          specifying the Date of Termination (as defined below). The failure by the Company to set forth in the Notice of Termination all of the facts and circumstances which contribute to a showing of Cause (as defined below) shall not waive any right of
          the Company hereunder or preclude the Company from asserting such fact or circumstance in enforcing its rights hereunder.

    

    
      

      

    

    
      (c)          Date of Termination. For purposes of this Agreement, “Date

            of Termination” shall mean the date of the termination of Executive’s employment with the Company specified in a Notice of Termination.

    

    
      

      

    

    
      (d)          Deemed Resignation. Upon termination of Executive’s employment for any reason, Executive shall be deemed to
          have resigned from all offices and board memberships, if any, then held with the Company or any of its affiliates, and, at the Company’s request, Executive shall execute such documents as are necessary or desirable to effectuate such
          resignations.

    

    
      

      

    

    
      6.          Consequences of Termination.

    

    
      

      

    

    
      (a)          Payments of Accrued Obligations upon all Terminations of Employment. Upon a termination of Executive’s
          employment for any reason, Executive (or Executive’s estate or legal representative, as applicable) shall be entitled to receive, within 30 days after Executive’s Date of Termination (or such earlier date as may be required by applicable law):
          (i) any portion of Executive’s Annual Base Salary earned through Executive’s Date of Termination not theretofore paid, (ii) any expenses owed to Executive under Section 3, (iii) any accrued but unused paid time off owed to Executive, solely to
          the extent applicable under the Company’s paid time off policies; (iv) any Annual Bonus earned but unpaid as of the Date of Termination, and (v) any amount arising from Executive’s participation in, or benefits under, any employee benefit plans,
          programs, or arrangements under Section 3, which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs, or arrangements. Except as otherwise set forth in Sections 6(b) and (c), the payments
          and benefits described in this Section 6(a) shall be the only payments and benefits payable in the event of Executive’s termination of employment for any reason.

    

    
      

      

    

    
      (b)          Severance Payments upon Covered Termination Outside a Change in Control Period. If, during the Term, Executive
          experiences a Covered Termination outside of a Change in Control Period (each as defined below), then in addition to the payments and benefits described in Section 6(a), the Company shall, subject to Executive’s delivery to the Company of a
          waiver and release of claims agreement in a form acceptable to the Company (the “Release”) that becomes effective and irrevocable in accordance with Section 10(d) and Executive’s
          continued compliance with the Confidentiality Agreement, provide Executive with the following:

    

    
      
        

    

    
      

      

    

    
      (i)          Executive shall be entitled to receive an amount equal to [________ (__)]4 months of Executive’s annual base salary at the rate in effect immediately prior to the Date of Termination, payable in a cash lump sum, less applicable withholdings, on the first payroll date
          following the date the Release becomes effective and irrevocable in accordance with Section 10(d).

    

    
      

      

    

    
      (ii)          If Executive timely elects to receive continued healthcare coverage pursuant to the provisions of the Consolidated
          Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall directly pay, or reimburse Executive for, the Company’s portion of the premium (at the same rates in
          effect on the Date of Termination) for Executive and Executive’s covered dependents through the earlier of (A) the [________ (__)]5 -month anniversary of the Date of
          Termination and (B) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s). Notwithstanding the foregoing, (x) if any plan pursuant to which such benefits are
          provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Section 409A of the Internal Revenue Code of 1986, as amended, (the “Code”) under Treasury Regulation Section 1.409A-1(a)(5), or (y) the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation,
          Section 2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to Executive in substantially equal monthly installments. After the Company ceases to pay premiums
          pursuant to this Section 6(b)(ii), Executive may, if eligible, elect to continue healthcare coverage at Executive’s expense in accordance with the provisions of COBRA. Executive shall notify the Company immediately if Executive becomes covered by
          a group health plan of a subsequent employer.

    

    
      

      

    

    
      (c)          Severance Payments upon Covered Termination During a Change in Control Period. If, during the Term, Executive
          experiences a Covered Termination during a Change in Control Period, then, in addition to the payments and benefits described in Section 6(a), the Company shall, subject to Executive’s delivery to the Company of the Release that becomes effective
          and irrevocable in accordance with Section 10(d) and Executive’s continued compliance with the Confidentiality Agreement, provide Executive with the following:

    

    
      

      

    

    
      (i)          Executive shall be entitled to receive an amount equal to the sum of (i) [________ (__)]6 months of Executive’s annual base salary at the rate in effect immediately prior to the Date of Termination and (ii) [________]7  times Executive’s target annual bonus assuming achievement of performance goals at one hundred percent (100%) of target, payable in a cash lump sum, less applicable withholdings, on the first payroll date following
          the date the Release becomes effective and irrevocable in accordance with Section 10(d).

    

    
      

      

    

    
      (ii)          If Executive timely elects to receive continued healthcare coverage pursuant to the provisions of COBRA, the Company
          shall directly pay, or reimburse Executive for, the Company’s portion of the premium (at the same rates in effect on the Date of Termination) for Executive and Executive’s covered dependents through the earlier of (i) the [________ (__)]8-month anniversary of the Date of Termination and (ii) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under
          another employer’s plan(s). Notwithstanding the foregoing, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Section
          409A of the Code under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation, Section
          2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to Executive in substantially equal monthly installments. After the Company ceases to pay premiums pursuant
          to this Section 6(c)(ii), Executive may, if eligible, elect to continue healthcare coverage at Executive’s expense in accordance with the provisions of COBRA. Executive shall notify the Company immediately if Executive becomes covered by a group
          health plan of a subsequent employer.

    

    

    

    

    4 Twelve (12) months for CEO; Nine (9) months for other executive officers.

    5 Twelve (12) months for CEO; Nine (9) months for other executive officers.

    6 Eighteen (18) months for CEO; Twelve (12) months for other executive officers.

    7 One and one-half (1.5) for CEO; One (1) for other executive officers.

    8 Eighteen (18) months for CEO; Twelve (12) months for other executive officers.

    
      
        

    

    
      

      

    

    
      (iii)          Each outstanding and unvested equity award, including, without limitation, each stock option, restricted stock unit
          and stock appreciation right, held by Executive shall automatically become vested and, if applicable, exercisable and any forfeiture restrictions or rights of repurchase thereon shall immediately lapse with respect to one hundred percent (100%)
          of the shares subject thereto, as of immediately prior to the Date of Termination; provided that the treatment of performance targets with respect to each equity award subject to performance-based vesting shall be as specified in the award
          agreement and such provision in the applicable award agreement shall control.

    

    
      

      

    

    
      (d)          No Other Severance. Except as otherwise approved by the Board, the provisions of this Section 6 shall
          supersede in their entirety any severance payment provisions in any severance plan, policy, program, or other arrangement maintained by the Company, including without limitation, the Offer Letter.

    

    
      

      

    

    
      (e)          No Requirement to Mitigate; Survival. Executive shall not be required to mitigate the amount of any payment
          provided for under this Agreement by seeking other employment or in any other manner. Notwithstanding anything to the contrary in this Agreement, the termination of Executive’s employment shall not impair the rights or obligations of any Party.

    

    
      

      

    

    
      (f)          Definition of Cause. For purposes
          hereof, “Cause” means: (i) Executive’s material and repeated failure to perform Executive’s assigned duties or responsibilities as an
          officer of the Company (other than a failure resulting from Executive’s Disability (as defined herein)) after written notice thereof from the Company describing Executive’s failure to perform such duties or responsibilities and reasonable opportunity to cure such performance failure within a period of fifteen (15) calendar days following such notice from the Company; (ii) Executive’s engaging in any act of
          dishonesty, fraud or misrepresentation in relation to Executive’s duties to the Company; (iii) Executive’s violation of any federal or state law or regulation applicable to the business of the Company or its affiliates; (iv) Executive’s breach of
          any confidentiality agreement or invention assignment agreement between Executive and the Company (or any affiliate of the Company); (v) Executive’s material violation of written Company policies including but not limited to its Employee Handbook
          and Code of Conduct; or (vi) Executive’s commission of, or entering a plea of nolo contendere to, any crime or
          committing any act of moral turpitude.

    

    
      

      

    

    
      (g)          Definition of Change in Control. For purposes hereof, “Change

            in Control” has the meaning ascribed to such term under the Company’s 2021 Incentive Award Plan, as may be amended from time to time; provided, that such transaction must also constitute a
          “change in control event” within the meaning of Treasury Regulation Section 1.409A-3(i)(5).

    

    
      

      

    

    
      (h)          Definition of Change in Control Period. For purposes hereof, “Change in Control Period” shall mean the period commencing on a Change in Control and ending 12 months after such Change in Control.

    

    
      

      

    

    
      (i)          Definition of Covered Termination. For purposes hereof, “Covered

            Termination” shall mean the termination of Executive’s employment by the Company without Cause or by Executive for Good Reason. For the avoidance of doubt, a Covered Termination shall not include a termination due to Executive’s death or
          disability.

    

    
      

      

    

    
      (j)          Definition of Disability. For purposes hereof, “Disability”
          has the meaning set forth under the long-term disability policy of the Company or a related entity to which Executive provides services regardless of whether Executive is covered by such policy. If the Company or the related entity to which
          Executive provides service does not have a long-term disability plan in place, “Disability” means that Executive is unable to carry out the responsibilities and functions of the position held by Executive by reason of any medically determinable
          physical or mental impairment for a period of not less than ninety (90) consecutive days. Executive will not be considered to have incurred a Disability unless Executive furnishes proof of such impairment sufficient to satisfy the Board in its
          discretion.

    

    
      
        

    

    
      

      

    

    
      (k)          Definition of Good Reason. For purposes hereof, “Good
            Reason” for Executive to terminate Executive’s employment hereunder shall mean the occurrence of any of the following events without Executive’s consent: (i) a material reduction in Executive’s salary, other than as a result of a similar
          reduction in compensation affecting employees of the Company, or its successor entity, generally; (ii) a material diminution in Executive’s authority, duties or responsibilities; or (iii) relocation of Executive’s place of employment to a
          location more than fifty (50) miles from the Company’s office location, provided, in each case, that if any of the events set forth above shall occur, Executive shall give written notice of such event to the Company, or its successor entity,
          within thirty (30) days following such event, and if such event is not cured within thirty (30) calendar days from such notice (the “Good Reason Cure Period”) Executive may exercise Executive’s rights to resign for Good Reason, provided that if Executive has not exercised such right within forty-five (45) days of the expiration of the Good Reason Cure Period
          Executive shall be deemed to have agreed to the occurrence of such event.

    

    
      

      

    

    
      7.          Assignment and Successors. The Company shall assign its
          rights and obligations under this Agreement to any successor to all or substantially all of the business or the assets of the Company (by merger or otherwise). This Agreement shall be binding upon and inure to the benefit of the Company,
          Executive, and their respective successors, assigns, personnel, and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive’s rights or obligations may be assigned or
          transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only by will, operation of law, or as otherwise provided herein.

    

    
      

      

    

    
      8.          Miscellaneous Provisions.

    

    
      

      

    

    
      (a)          Confidentiality Agreement. Concurrent with the execution of this Agreement, Executive has entered into and
          hereby affirms Executive’s obligations under that certain At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement or other confidentiality agreement by and between the Company and Executive (the “Confidentiality Agreement”). The Confidentiality Agreement shall survive the termination of this Agreement and Executive’s employment with the Company for the applicable period(s) set forth
          therein. Notwithstanding the foregoing, in the event of any conflict between the terms of the Confidentiality Agreement and the terms of this Agreement, the terms of this Agreement shall prevail.

    

    
      

      

    

    
      (b)          Governing Law. This Agreement shall be governed, construed, interpreted, and enforced in accordance with its
          express terms, and otherwise in accordance with the substantive laws of the State of California, without giving effect to any principles of conflicts of law, whether of the State of California or any other jurisdiction, and where applicable, the
          laws of the United States, that would result in the application of the laws of any other jurisdiction.

    

    
      

      

    

    
      (c)          Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not
          affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.

    

    
      

      

    

    
      (d)          Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an
          original, but all of which together will constitute one and the same Agreement. Signatures delivered by facsimile shall be deemed effective for all purposes.

    

    
      

      

    

    
      (e)          Entire Agreement. The terms of this Agreement, together with the Confidentiality Agreement, are intended by
          the Parties to be the final expression of their agreement with respect to the employment of Executive by the Company and supersede all prior understandings and agreements, whether written or oral, regarding Executive’s service to the Company,
          including without limitation, the Offer Letter; provided, that the terms of any award agreements governing stock options outstanding on the date hereof shall continue to govern the terms of such stock options to the extent more favorable to the
          Executive. The Parties further intend that this Agreement, together with the Confidentiality Agreement, shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any
          judicial, administrative, or other legal proceeding to vary the terms of this Agreement or the Confidentiality Agreement. Notwithstanding the foregoing, in the event of any conflict between the terms of the Confidentiality Agreement and the terms
          of this Agreement, the terms of this Agreement shall prevail.

      
        
          

      

      

      

      (f)          Amendments; Waivers. This Agreement may not be modified, amended, or terminated except by an instrument in
          writing signed by Executive and a duly authorized representative of the Company. By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company, as applicable, may waive compliance by the other Party with
          any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform; provided, however, that such waiver
          shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder shall preclude any other or further exercise of any other
          right, remedy, or power provided herein or by law or in equity.

    

    
      

      

    

    
      (g)          Dispute Resolution. To ensure the timely and economical resolution of disputes that arise in connection with
          this Agreement, Executive and the Company agree that, except as excluded herein, any and all controversies, claims and disputes arising out of or relating to this Agreement, including without limitation any alleged violation of its terms or
          otherwise arising out of the Parties’ relationship, shall be resolved solely and exclusively by final and binding arbitration held in Alameda County, California through JAMS in conformity with California law and the then-existing JAMS employment
          arbitration rules, which can be found at https://www.jamsadr.com/rules-employment-arbitration/. The Federal Arbitration Act, 9 U.S.C. §§ 1 et seq. shall govern the interpretation and enforcement of this arbitration clause. All remedies
          available from a court of competent jurisdiction shall be available in the arbitration; provided, however, in the event of a breach of Section 8(a), the Company may request relief from a court of competent jurisdiction if such relief is not
          available or not available in a timely fashion through arbitration as determined by the Company. The arbitrator shall: (a) provide adequate discovery for the resolution of the dispute; and (b) issue a written arbitration decision, to include the
          arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall award the prevailing Party attorneys’ fees and expert fees, if any. Notwithstanding the foregoing, it is acknowledged that it will be impossible to
          measure in money the damages that would be suffered if the Parties fail to comply with any of the obligations imposed on them under Section 8(a), and that in the event of any such failure, an aggrieved person will be irreparably damaged and will
          not have an adequate remedy at law. Any such person shall, therefore, be entitled to seek injunctive relief, including specific performance, to enforce such obligations, and if any action shall be brought in equity to enforce any of the
          provisions of Section 8(a), none of the Parties shall raise the defense, without a good faith basis for raising such defense, that there is an adequate remedy at law. Executive and the Company understand that by agreement to arbitrate any claim
          pursuant to this Section 8(g), they will not have the right to have any claim decided by a jury or a court, but shall instead have any claim decided through arbitration. Executive and the Company waive any constitutional or other right to bring
          claims covered by this Agreement other than in their individual capacities. Except as may be prohibited by applicable law, the foregoing waiver includes the ability to assert claims as a plaintiff or class member in any purported class or
          collective action or representative proceeding. Nothing herein shall limit Executive’s ability to pursue claims for workers compensation or unemployment benefits or pursue other claims which by law cannot be subject to mandatory arbitration.

    

    
      

      

    

    
      (h)          Enforcement. If any provision of this Agreement is held to be illegal, invalid, or unenforceable under
          present or future laws, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid, or unenforceable provision had never comprised a portion of this Agreement; and the remaining provisions
          of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid, or unenforceable
          provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid, or unenforceable provision as may be possible and be legal, valid, and enforceable.

    

    
      

      

    

    
      (i)          Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any
          federal, state, local, or foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding
          shall arise.

    

    
      
        

    

    
      

      

    

    
      (j)          Whistleblower Protections and Trade Secrets. Notwithstanding anything to the contrary contained herein,
          nothing in this Agreement prohibits Executive from reporting possible violations of federal law or regulation to any United States governmental agency or entity in accordance with the provisions of and rules promulgated under Section 21F of the
          Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002, or any other whistleblower protection provisions of state or federal law or regulation (including the right to receive an award for information provided to any such
          government agencies). Furthermore, in accordance with 18 U.S.C. § 1833, notwithstanding anything to the contrary in this Agreement: (i) Executive shall not be in breach of this Agreement, and shall not be held criminally or civilly liable under
          any federal or state trade secret law (x) for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected
          violation of law, or (y) for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) if Executive files a lawsuit for retaliation by the
          Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney, and may use the trade secret information in the court proceeding, if Executive files any document containing the trade secret
          under seal, and does not disclose the trade secret, except pursuant to court order.

    

    
      

      

    

    
      9.          Golden Parachute Excise Tax.

    

    
      

      

    

    
      (a)          Best Pay. Any provision of this Agreement to the contrary notwithstanding, if any payment or benefit
          Executive would receive from the Company pursuant to this Agreement or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code and
          (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Reduced Amount (as defined below).
          The “Reduced Amount” will be either (A) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax or (B) the
          entire Payment, whichever amount after taking into account all applicable federal, state, and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate, net of the maximum reduction in federal
          income taxes which could be obtained from a deduction of such state and local taxes), results in Executive’s receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to
          the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant to clause (A) of the preceding sentence, the reduction shall occur in the manner (the “Reduction Method”) that results in the greatest economic benefit for Executive. If more than one method of reduction will result in the same economic benefit, the items so reduced will be
          reduced pro rata (the “Pro Rata Reduction Method”). Notwithstanding the foregoing, if the Reduction Method or the Pro Rata Reduction Method would result in any portion of the Payment
          being subject to taxes pursuant to Section 409A (as defined below) that would not otherwise be subject to taxes pursuant to Section 409A, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as
          to avoid the imposition of taxes pursuant to Section 409A as follows: (1) as a first priority, the modification shall preserve to the greatest extent possible, the greatest economic benefit for Executive as determined on an after-tax basis; (2)
          as a second priority, Payments that are contingent on future events (e.g., being terminated without cause), shall be reduced (or eliminated) before Payments that are not contingent on future events; and
          (3) as a third priority, Payments that are “deferred compensation” within the meaning of Section 409A shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A.

    

    
      

      

    

    
      (b)          Accounting Firm. The accounting firm engaged by the Company for general tax purposes as of the day prior to
          the Change in Control will perform the calculations set forth in Section 9(a). If the firm so engaged by the Company is serving as the accountant or auditor for the acquiring company, the Company will appoint a nationally recognized accounting
          firm to make the determinations required hereunder. The Company will bear all expenses with respect to the determinations by such firm required to be made hereunder. The accounting firm engaged to make the determinations hereunder will provide
          its calculations, together with detailed supporting documentation, to the Company within thirty (30) days before the consummation of a Change in Control (if requested at that time by the Company) or such other time as requested by the Company. If
          the accounting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it will furnish the Company with documentation reasonably acceptable to the Company that no
          Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the accounting firm made hereunder will be final, binding and conclusive upon the Company and Executive.

    

    
      
        

    

    
      

      

    

    
      10.          Section 409A.

    

    
      

      

    

    
      (a)          General. The intent of the Parties is that the payments and benefits under this Agreement comply with or be
          exempt from Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective Date, (“Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. Notwithstanding any provision of this Agreement to the
          contrary, if the Company determines that any compensation or benefits payable under this Agreement may be subject to Section 409A, the Company shall work in good faith with Executive to adopt such amendments to this Agreement or adopt other
          policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Company determines are necessary or appropriate to avoid the imposition of taxes under Section 409A, including,
          without limitation, actions intended to (i) exempt the compensation and benefits payable under this Agreement from Section 409A, and/or (ii) comply with the requirements of Section 409A; however, this Section 10(a) shall not create an obligation
          on the part of the Company to adopt any such amendment, policy or procedure or take any such other action, nor shall the Company (A) have any liability for failing to do so, or (B) incur or indemnify Executive for any taxes, interest or other
          liabilities arising under or by operation of Section 409A.

    

    
      

      

    

    
      (b)          Separation from Service, Installments and Reimbursements. Notwithstanding

          any provision to the contrary in this Agreement: (i) no amount that constitutes “deferred compensation” under Section 409A shall be payable pursuant to Section 6 unless the termination of Executive’s employment constitutes a “separation from
          service” within the meaning of Section 1.409A-1(h) of the Department of Treasury Regulations (“Separation from Service”); (ii) for purposes of Section 409A, Executive’s right to receive
          installment payments shall be treated as a right to receive a series of separate and distinct payments; and (iii) to the extent that any reimbursement of expenses or in-kind benefits constitutes “deferred compensation” under Section 409A, such
          reimbursement or benefit shall be provided no later than December 31st of the year following the year in which the expense was incurred. The amount of expenses
          reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided in any other year.

    

    
      

      

    

    
      (c)          Specified Employee. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by
          the Company at the time of Executive’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is
          required in order to avoid a prohibited distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six-month period measured from the date of
          Executive’s Separation from Service with the Company or (ii) the date of Executive’s death. Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall
          be paid in a lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein.

    

    
      

      

    

    
      (d)          Release. Notwithstanding anything to the contrary in this Agreement, to the extent that any payments due
          under this Agreement as a result of Executive’s termination of employment are subject to Executive’s execution and delivery of the Release, (i) if Executive fails to execute the Release on or prior to the Release Expiration Date (as defined
          below) or timely revokes Executive’s acceptance of the Release thereafter, Executive shall not be entitled to any payments or benefits otherwise conditioned on the Release, and (ii) in any case where Executive’s Date of Termination and the last
          day the Release may be considered or, if applicable, revoked, fall in two separate taxable years, any payments required to be made to Executive that are conditioned on the Release and are treated as nonqualified deferred compensation for purposes
          of Section 409A shall be made in the later taxable year. For purposes of this Section 10(d), “Release Expiration Date” shall mean (1) if Executives is under 40 years old as of the Date
          of Termination, the date that is seven (7) days following the date upon which the Company timely delivers the Release to Executive, and (2) if Executive is 40 years or older as of the Date of Termination, the date that is 21 days following the
          date upon which the Company timely delivers the Release to Executive, or, in the event that Executive’s termination of employment is “in connection with an exit incentive or other employment termination program” (as such phrase is defined in the
          Age Discrimination in Employment Act of 1967), the date that is 45 days following such delivery date. To the extent that any payments of nonqualified deferred compensation (within the meaning of Section
          409A) due under this Agreement as a result of Executive’s termination of employment are delayed pursuant to this Section 10(d), such amounts shall be paid in a lump sum on the first payroll date following the date that Executive executes and does
          not revoke the Release (and the applicable revocation period has expired) or, in the case of any payments subject to Section 10(d)(ii), on the first payroll period to occur in the subsequent taxable year, if later.

    

    
      

      

    

    
      11.          Employee Acknowledgement. Executive acknowledges that
          Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this
          Agreement freely based on Executive’s own judgment.

    

    
      

      

    

    
      [Signature Page Follows]

    

    
      
        

    

    
      

      

      The Parties have executed this Agreement as of the date first set forth above.

      

      

    

    	 	
            ZYMERGEN INC.

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 
	 	 
	 	
            EXECUTIVE

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	 

    

    

    
      
        

    

    

    

    
      EXHIBIT A

      

      

      PERMITTED OUTSIDE ACTIVITIES

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]